Xilio Therapeutics, Inc.
Biotechnology ResearchView the employees at
Xilio Therapeutics, Inc.-
Katharine Rausch (Kate) Director, Digital Forces
-
Rising Star
Susan Uptain, Ph.D. Vice President, Program Leadership at Xilio Therapeutics, Inc.-
Rising Star
Damiano Fantini Associate Director at $XLO - Bioinformatics | Translational Oncology-
Boston, Massachusetts, United States
-
Rising Star
Will Scott, PhD Scientist | R&D | Oncology | Immunoassays | Proteomics-
Greater Boston
-
Rising Star
Haley D. Research Associate In Vivo Pharmacology. Certified Veterinary Technician.-
Greater Boston
-
Rising Star
Overview
Xilio is a Waltham, Massachusetts-based clinical-stage biopharmaceutical company focused on defeating cancer. The company’s proprietary technology enables the explosion of therapeutic activity specifically within the tumor while reducing toxicity throughout the body – a nod to the company name, Xilio, derived from the Latin term, Ex Nihilo, meaning creation or big-bang. Xilio is applying its technology to build a broad pipeline of engineered antibodies, cytokines and chemokines as potential new options for people living with cancer.
-